Sirna Therapeutics' Acquisition

Sirna Therapeutics was acquired by Alnylam Pharmaceuticals on March 06, 2014.

Sirna Therapeutics develops treatments based on RNAi technology for asthma, diabetes, hepatitis C, macular degeneration and Huntington's Disease.…

Articles about Sirna Therapeutics' Acquisition: